-- マーシャル・フォーダイス取締役社長兼CEOは、2026年4月14日、ベラ・セラピューティクス（VERA）の株式22,951株を1,011,051ドルで売却しました。SECへのフォーム4提出後、フォーダイス氏は同社のクラスA普通株式合計457,274株を保有することになり、そのうち235,244株は直接保有、222,030株は間接的に保有しています。 SEC提出書類：https://www.sec.gov/Archives/edgar/data/1831828/000185945326000006/xslF345X05/form4-04152026_080434.xml
Related Articles
Research
Rothschild & Co Redburn Upgrades Rollins to Buy From Neutral, Adjusts PT to $66 From $51.90
Rollins (ROL) has an average rating of overweight and mean price target of $65.20, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$ROL
Research
Arete Research Upgrades Fortinet to Buy From Sell, Adjusts Price Target to $104 From $83
Fortinet (FTNT) has an average rating of hold and mean price target of $88.45, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$FTNT
Research
BNP Paribas Downgrades GE Vernova to Neutral From Outperform, Adjusts PT to $1,190 From $765
GE Vernova (GEV) has an average rating of overweight and mean price target of $1,179.31, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$GEV